David V Goeddel is Director of NGM BIOPHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of NGM, which is worth approximately $0. The most recent transaction as insider was on Apr 05, 2024, when has been sold 134,180 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

DAVID V GOEDDEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 05 2024
SELL
Sale (or disposition) back to the issuer
-
134,180 Reduced 100.0%
0 Common Stock
Nov 16 2023
BUY
Open market or private purchase
$905 $0.62 p/Share
1,460 Added 1.08%
134,180 Common Stock
Nov 15 2023
BUY
Open market or private purchase
$1,931 $0.71 p/Share
2,720 Added 2.01%
132,720 Common Stock
Oct 17 2022
BUY
Open market or private purchase
$159,000 $3.18 p/Share
50,000 Added 27.78%
130,000 Common Stock

Also insider at

TNYA
Tenaya Therapeutics, Inc. Healthcare
DVG

David V Goeddel

Director
San Francisco, CA

Track Institutional and Insider Activities on NGM

Follow NGM BIOPHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NGM shares.

Notify only if

Insider Trading

Get notified when an Ngm Biopharmaceuticals Inc insider buys or sells NGM shares.

Notify only if

News

Receive news related to NGM BIOPHARMACEUTICALS INC

Track Activities on NGM